Claros Diagnostics

OPKO Health, Inc. is a fully integrated healthcare company dedicated to improving patients' lives through the development of next-generation solutions for serious diseases across established global markets. With an accomplished management team and strategic partnerships with leading pharmaceutical companies, OPKO Health is committed to advancing proven technologies that transform patient care.

The company offers innovative therapies, including NGENLA, an FDA-approved human growth hormone treatment, and RAYALDEE, while also operating BioReference Laboratories, one of the largest full-service clinical reference laboratories in the U.S. OPKO Health focuses on research aimed at developing multispecific therapies to address the complex drivers of serious conditions such as cancers and infectious diseases.

Generated from the website